Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Sensus Healthcare Inc (SRTS)

43 + Investors. Track Smart Money conviction in SRTS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -1
Streak
1Q ▼
Buyers last Q
43%

Smart Money Signals — SRTS

Based on 43 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their SRTS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 67% of 3.0Y high

67% of all-time peak
Only 43 funds hold SRTS today versus a peak of 64 funds at 2024 Q4 — just 67% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 19% fewer funds vs a year ago

fund count last 6Q
10 fewer hedge funds hold SRTS compared to a year ago (-19% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 43% buying

15 buying20 selling
Last quarter: 20 funds reduced or exited vs 15 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~6 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 5 → 4 → 6 → 6. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

51% of holders stayed for 2+ years

■ 51% conviction (2yr+) ■ 26% medium ■ 23% new
22 out of 43 hedge funds have held SRTS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~6 new funds/quarter

13 → 5 → 4 → 6 → 6 new funds/Q
New funds entering each quarter: 5 → 4 → 6 → 6. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 53% veterans vs 37% newcomers

■ 53% veterans ■ 9% 1-2yr ■ 37% new
Entry-cohort mix of 43 holders: 23 (53%) are 2+ year veterans, 4 entered 1–2 years ago, and 16 (37%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 27% AUM from major funds

27% from top-100 AUM funds
12 of 40 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.3
out of 10
Low Exit Risk
Exit risk score 2.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SRTS

In 2026 Q1, 15 hedge funds were net buyers of SRTS (6 opened a new position, 9 added to an existing one), while 20 reduced or exited (13 trimmed, 7 sold completely) — a 43% buyer ratio, indicating roughly balanced activity. 27% of total institutional value in SRTS is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -1 funds (more exits than new entries). Total institutional holders: 43.

Hedge Fund Ownership: SRTS

How many hedge funds hold SRTS — quarterly history vs. share price
Quarterly hedge fund ownership of SRTS vs. share price

Market Analysis: SRTS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SRTS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Sensus Healthcare Inc (SRTS) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SRTS has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
SRTS
-31.3%
XLV
+1.6%

SRTS outperformed XLV by -32.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
SRTS
-19.6%
XLV
+2.7%

Since the filing became public, SRTS outperformed XLV by -22.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 0 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
0.4
/ 10
conviction
Hedge Fund Positioning: SRTS
43 + Investors

Track Smart Money conviction in SRTS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 43 44 -2.27%
13F Shares 4M 4M -2.09%
Total Value $16M $16M -4.81%
New Positions 6 6 -
Increased Positions 9 9 -
Closed Positions 7 5 +2
Reduced Positions 13 14 -1
Total Calls 3 1 200.0%
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 1.0 Bullish

Statistics: SRTS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

43 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SRTS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 SRTS holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Pacific Ridge Capital Partners, LLC 0.69% 796,072 $3.2M
2 Greenline Wealth Management LLC 0.59% 128,774 $513K
3 Sachetta, LLC 0.32% 150,508 $599K
4 Meros Investment Management, LP 0.26% 152,418 $607K
5 Mindset Wealth Management, LLC 0.06% 52,100 $207K
6 Divisadero Street Capital Management, LP 0.05% 286,078 $1.1M
7 North Star Investment Management Corp. 0.03% 125,586 $500K
8 Chapin Davis, INC. 0.02% 26,000 $103K
9 Opes Wealth Management LLC 0.01% 16,065 $64K
10 Renaissance Technologies LLC 0.00% 252,234 $1.0M
11 Ashton Thomas Private Wealth, LLC 0.00% 15,668 $62K
12 Vise Technologies, Inc. 0.00% 11,000 $44K
13 AlphaQuest LLC 0.00% 1,571 $6K
14 Peak6 LLC 0.00% 19,200 $76K
15 UBS Group AG 0.00% 172,870 $688K
16 Larson Financial Group LLC 0.00% 800 $3K
17 Vanguard Fiduciary Trust Co 0.00% 75,730 $301K
18 Vanguard Capital Management LLC 0.00% 648,225 $2.6M
19 Rockefeller Capital Management L.P. 0.00% 7,000 $28K
20 American Century Companies Inc 0.00% 21,272 $85K
21 Farther Finance Advisors, LLC 0.00% 1,081 $5K
22 Tower Research Capital LLC (TRC) 0.00% 118 —
23 Susquehanna International Group, LLP 0.00% 26,300 $105K
24 Jane Street Group, LLC 0.00% 22,352 $89K
25 Citadel Advisors LLC 0.00% 14,600 $58K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Sensus Healthcare Inc (SRTS)

What does the Smart Money Trend signal show for SRTS?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their SRTS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for SRTS?

More sellers than buyers — 43% buying: Last quarter: 20 funds reduced or exited vs 15 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for SRTS holders?

Strong quality — 27% AUM from major funds: 12 of 40 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held SRTS?

51% of holders stayed for 2+ years: 22 out of 43 hedge funds have held SRTS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Sensus Healthcare Inc (SRTS) following the 2026 Q1 hedge fund 13F filings?

As of today, SRTS has moved -19.6% since the 2026 Q1 13F filing date (May 15, 2026), compared to +2.7% for the XLV sector ETF — an outperformance of -22.3%. Since the quarter end (March 31, 2026), SRTS has gained -31.3% vs +1.6% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →